Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$161.02 - $206.98 $117 Million - $150 Million
-726,517 Reduced 72.86%
270,652 $54.6 Million
Q1 2024

May 15, 2024

SELL
$163.6 - $209.11 $1.27 Million - $1.63 Million
-7,777 Reduced 0.77%
997,169 $171 Million
Q4 2023

Feb 14, 2024

SELL
$127.77 - $221.42 $104 Million - $181 Million
-816,000 Reduced 44.81%
1,004,946 $218 Million
Q3 2023

Nov 14, 2023

BUY
$154.67 - $290.89 $170 Million - $319 Million
1,097,708 Added 151.78%
1,820,946 $290 Million
Q2 2023

Aug 14, 2023

BUY
$272.48 - $330.23 $76.6 Million - $92.8 Million
281,000 Added 63.54%
723,238 $209 Million
Q1 2023

May 15, 2023

SELL
$276.36 - $326.03 $147 Million - $174 Million
-533,135 Reduced 54.66%
442,238 $141 Million
Q4 2022

Feb 14, 2023

SELL
$212.22 - $313.46 $74.9 Million - $111 Million
-352,823 Reduced 26.56%
975,373 $287 Million
Q3 2022

Nov 14, 2022

BUY
$224.6 - $281.45 $20.7 Million - $26 Million
92,376 Added 7.47%
1,328,196 $305 Million
Q2 2022

Aug 15, 2022

SELL
$186.4 - $279.02 $38.4 Million - $57.5 Million
-206,152 Reduced 14.3%
1,235,820 $269 Million
Q1 2022

May 16, 2022

SELL
$194.8 - $275.7 $48.9 Million - $69.2 Million
-250,885 Reduced 14.82%
1,441,972 $384 Million
Q4 2021

Feb 14, 2022

BUY
$255.32 - $318.29 $94.2 Million - $117 Million
368,775 Added 27.85%
1,692,857 $450 Million
Q3 2021

Nov 15, 2021

BUY
$260.36 - $307.27 $83.9 Million - $99 Million
322,082 Added 32.14%
1,324,082 $376 Million
Q2 2021

Aug 16, 2021

BUY
$225.52 - $304.06 $226 Million - $305 Million
1,002,000 New
1,002,000 $275 Million
Q1 2019

May 15, 2019

SELL
$72.44 - $101.87 $121 Million - $171 Million
-1,675,000 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$73.27 - $105.19 $123 Million - $176 Million
1,675,000 New
1,675,000 $133 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track D1 Capital Partners L.P. Portfolio

Follow D1 Capital Partners L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D1 Capital Partners L.P., based on Form 13F filings with the SEC.

News

Stay updated on D1 Capital Partners L.P. with notifications on news.